611 MYLAN (Methyldopa 250 mg)
Pill imprint 611 MYLAN has been identified as Methyldopa 250 mg.
Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 611 MYLAN (Methyldopa 250 mg)
- 250 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
FD&C Yellow No. 6
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|51079-0200||UDL Laboratories Inc|
|54569-0508||A S Medication Solutions LLC (repackager)|
Note: Inactive ingredients may vary.
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...